The results of a Phase 1 trial suggest that the experimental drug PD 0332991 may be a safe and effective treatment for pre-treated multiple myeloma patients.

Dr. Ruben Niesvizky of the Weill Cornell Medical College, who presented the results at the American Society of Hematology (ASH) annual meeting in Orlando last month, pointed out that data about efficacy is limited at this point because it was a Phase 1 trial. However, he added “We are encouraged [by the results] because …

Happy New Year!

As the hustle and bustle of the holiday season fades away in the rear-view mirror, I find myself entering the third year of my journey living with a diagnosis of multiple myeloma.

And as with many things in life, I have learned as much about what NOT to do, as what to do. Sometimes the lessons haven’t been easy.

Therefore, in 2011, I hereby resolve:

1. To stop referring to my pain medication as ‘Oxy-cotton-candy’. …

Results of a Phase 1 clinical trial suggest that the cancer drug Treanda, in combination with Revlimid and dexamethasone, is highly active and well tolerated in relapsed and refractory multiple myeloma patients.

Dr. Suzanne Lentzsch, of the University of Pittsburgh School of Medicine and Cancer Institute, presented the results of the study at the American Society of Hematology (ASH) 2010 annual meeting in Orlando.

Based on the safety of the Treanda, Revlimid, dexamethasone regimen observed in this study, Dr. Lentzsch …

The results of a number of clinical trials for the treatment of multiple myeloma with Zolinza were presented at the American Society of Hematology (ASH) 2010 annual meeting. The trials, ranging from Phase 1 to Phase 3, studied Zolinza in combination with a variety of approved myeloma drugs for the treatment of both early and advanced stages of the disease.

Zolinza (vorinostat) is manufactured by Merck Pharmaceuticals.  It is currently approved for a certain type of lymphoma and is …

Based on comments on my first article about nutritional supplements that I wrote a couple of weeks ago, I was able to identify four important questions anyone should consider before deciding to take a nutritional supplement:

What benefits do you hope to achieve? Are the contents in the bottle what the label says they are? How much do they cost? Are there any risks to taking them?

All good questions. But I would like to stay focused on the …

Strings of colored lights brighten the darkness of the season. Last week, a winter solstice full moon ornamented the sky with a radiant glow. I hoped to catch a glimpse of the rare lunar eclipse, but all I could see from my location was a veil of snowy clouds behind tall treetops—no moon glow in sight. And so it is living with multiple myeloma—much is hidden from view, such as abnormal cells and holes in bones.

Soon we mark the …

As the 2010 holiday season reaches it peak, all of us here at The Myeloma Beacon would like to thank you, our readers, for giving us the greatest gift possible: your time.  We appreciate your coming to The Beacon and reading our articles, sharing your thoughts about them with us, and discussing them – and many other topics! – in our forums.

The holiday season is a time of many different traditions.  It also is a busy time, when it …